Astrazeneca stock closed at $66.26, down 0.39% from previous day, showing relative stability

From Nasdaq: 2024-12-27 18:15:21

In the latest trading session, Astrazeneca (AZN) closed at $66.26, down 0.39% from the previous day, a narrower drop than the S&P 500’s 1.11% loss. The stock has fallen by 1.01% in the past month, exceeding the Medical sector’s 4.56% decline.

Investors are anticipating Astrazeneca’s upcoming earnings release, with a forecasted EPS of $1.06 and revenue of $14.26 billion. Analyst estimate revisions can impact stock performance, with a Zacks Rank of #3 (Hold) currently for Astrazeneca.

Astrazeneca’s valuation includes a Forward P/E ratio of 16.18, higher than the industry average of 13.89. The stock also has a PEG ratio of 1.19, below the industry average of 1.47. The Zacks Industry Rank for Large Cap Pharmaceuticals is 138 out of over 250, in the bottom 46%.

Zacks is naming its top 10 stocks for 2025, with a history of impressive performance compared to the S&P 500. The Zacks Top 10 Stocks have gained over 2000% since 2012, and the new picks for 2025 will be released on January 2. Don’t miss out on these potential market leaders.



Read more at Nasdaq: Astrazeneca (AZN) Stock Moves -0.39%: What You Should Know